Home LiteratureArticle Details
PMID: 17353538 Published · ppublish English Letter Comment

Possible patient overlap in studies.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne ·Vol. 176 ·No. 6 ·2007-03-13 ·Pages 809; author reply 809

Porath A

Abstract

暂无摘要

MeSH Terms
Clostridioides difficile/isolation & purification Clostridium Infections/drug therapy,epidemiology,etiology Female Follow-Up Studies Humans Incidence Male Proton Pump Inhibitors Proton Pumps/adverse effects,therapeutic use Retrospective Studies Risk Assessment United Kingdom/epidemiology Vancomycin/therapeutic use
Chemicals
Proton Pump Inhibitors Proton Pumps Vancomycin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Porath Adam
References (2)
2 references, click to expand
  1. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.
    JAMA. 2005 Dec 21;294(23):2989-95 PMID: 16414946
  2. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy.
    CMAJ. 2006 Sep 26;175(7):745-8 PMID: 17001054
Article Info
Journal
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Abbr.
CMAJ
ISSN
1488-2329
Published
2007-03-13
Pages
809; author reply 809
Language
English
Region
Canada
NLM ID
9711805
PMCID
PMC1808508
Subset
IM
Corrections
CommentOn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]